Virios therapeutics to report first quarter 2024 financial results on thursday, may 9, 2024

Atlanta, may 02, 2024 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri) (the “company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“fm”) and long-covid (“lc”), announced today that it will report first quarter 2024 financial results on thursday, may 9, 2024 before the open of the financial markets. management will also host a webcast and conference call on may 9, 2024 at 8:30 a.m. et to discuss the results and provide a corporate update.
VIRI Ratings Summary
VIRI Quant Ranking